Andreas Fibig to Leave Bayer HealthCare
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.
Andreas Fibig, president of Bayer HealthCare Pharmaceuticals, will leave the company to become CEO of International Flavors & Fragrances on Sept. 1, 2014. Bayer said it would nominate a successor shortly.

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.